Abstract
Background and aims: The non-steroidal anti-inflammatory drugs (NSAID) induced mucosal lesions are well-known and well-defined in the gastroduodenal tract. Much less in known about the NSAID provoked alterations in the small bowel, however a significant proportion of the patients take NSAIDs with a daily frequency. The aim of our prospective pilot capsule endoscopy (CE) study was to evaluate the small bowel mucosal pathology in patients with continuous NSAID intake.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
